Line-Related Thrombosis: How Long to Anticoagulate After?
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn:
Important clinical update on catheter-related thrombosis management
As clinicians, we often face questions about anticoagulation duration after catheter removal. The evidence suggests:
- NCCN guidelines recommend a minimum 3-month treatment for thrombosis, particularly in active malignancy
- Emerging evidence shows 1-month regimens may be sufficient in selected cases, with promising outcomes
- Patient-specific factors matter: cancer remission status significantly reduces recurrence risk (2.3%)
Key considerations include balancing thrombosis recurrence (4.8% at 1 year) against major haemorrhage risks (2.8-4.9%)
What’s your experience with anticoagulation duration in these cases? Would love to hear colleagues’ perspectives.”
Read the full review post here.
Review Post: For catheter or line-related thrombosis where removal is necessary, how long should anticoagulation be continued?
Author: Abdul Mannan
Stay informed on all guideline updates with Hemostasis Today.
-
Aug 22, 2025, 04:28Line-Related Thrombosis: How Long to Anticoagulate After?
-
Aug 21, 2025, 16:16Reza Shojaei on Redefining Blood Waste: The Future of Biotech and Healing
-
Aug 21, 2025, 16:01TAILORED-CHIP Trial: Time-Dependent Antiplatelet Therapy in High-Risk PCI
-
Aug 21, 2025, 15:54On the Chessboard of Blood Donation: Abdul Mannan Reviews a Complex Case
-
Aug 21, 2025, 15:31Flora Peyvandi on AI in Clinical Supervision: Educational Strategies
-
Aug 22, 2025, 04:10Emmanuel J Favaloro Shares 3 Latest Reviews on VTE, DIC, HSCT and Machine Learning
-
Aug 22, 2025, 03:37Lupus Anticoagulant-Hypoprothrombinemia Syndrome: Review by Doris Barcellona and Colleagues
-
Aug 21, 2025, 15:48World Federation of Hemophilia on Inhibitors in Treatment
-
Aug 21, 2025, 14:00Wolfgang Miesbach, Flora Peyvandi and Glenn F Pierce on Malignancy in Persons with Haemophilia
-
Aug 20, 2025, 14:25Mattia Galli: Sex-related Differences in Platelet Reactivity in Patients Both On and Off Antiplatelet Therapy
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Aug 21, 2025, 15:08Global Variations in Blood Collection: What Explains the Differences?
-
Aug 20, 2025, 13:33Askat's Life with Hemophilia A after Access to Prophylactic Treatment Through the WFH Humanitarian Aid Program
-
Aug 19, 2025, 17:22Louise Bannon Encourages You to Support World Thrombosis Day!
-
Aug 17, 2025, 07:31Melissa Korn's story: Recognizing Pulmonary Embolism Symptoms Can Save Lives, NBCA
-
Aug 16, 2025, 14:18Christelle Orlando Highlights Breakthroughs in Thrombophilia Testing and AT Assays at ISTH 2025